| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |